Sleep-Time Blood Pressure as a Therapeutic Target for Cardiovascular Risk Reduction in Type 2 Diabetes

Sleep-time BP is the most significant independent prognostic marker of cardiovascular events in diabetes. Most important, decreasing sleep-time BP, a novel therapeutic target requiring proper patient evaluation by ambulatory monitoring, was the most significant independent predictor of event-free survival in diabetes.